%0 Journal Article
%T Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival
%A Albrecht Stenzinger
%A Anna-Lena Volckmar
%A Claus-Peter Heussel
%A Felix J. Herth
%A Helge Bischoff
%A Holger S¨¹ltmann
%A Jan Budczies
%A Jonas Leichsenring
%A Martin Eichhorn
%A Martina Kirchner
%A Michael Allg£¿uer
%A Michael Meister
%A Michael Thomas
%A Olaf Neumann
%A Peter Schirmacher
%A Petros Christopoulos
%A Simon Ogrodnik
%A Steffen Dietz
%A Tomasz Zemojtel
%A Volker Endris
%J Archive of "Cancers".
%D 2019
%R 10.3390/cancers11010124
%K anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC)
%K tumor protein p53 gene (TP53) mutation
%K tyrosine kinase inhibitor
%K progression-free survival
%K overall survival
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356563/